A discussion on the radio about Regeneron said that the grant was to finance the manufacture of millions of doses before any proof of actual benefits. I think that is relevant to Brilacidin and I don't mind if anyone disagrees. Afterwards I contacted the host of the radio spot, Joel Barca Health and Science reporter for NPR, on Facebook with a link to Brilacidin press releases. Btw, just bought more IPIx at $0.36 today.